Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Bile duct obstruction
ADR ID BADD_A05411
ADR Hierarchy
09      Hepatobiliary disorders
09.02      Bile duct disorders
09.02.02      Obstructive bile duct disorders (excl neoplasms)
09.02.02.002      Bile duct obstruction
Description Impairment of bile flow due to obstruction in small bile ducts (INTRAHEPATIC CHOLESTASIS) or obstruction in large bile ducts (EXTRAHEPATIC CHOLESTASIS). [MeSH]
MedDRA Code 10056375
MeSH ID D002779; D002779; D057792
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Bile duct obstruction (excl calculus) | Bile duct obstruction due to calculus | Bile duct obstruction NOS | Calculus of bile duct without mention of cholecystitis, with obstruction | Extrahepatic biliary obstruction | Intrahepatic biliary obstruction | Obstruction of bile duct | Obstruction of cystic duct | Bile duct obstruction | Mirizzi syndrome | Cholestasis | Cholestases | Biliary Stasis | Biliary Stases | Stases, Biliary | Stasis, Biliary | Bile Duct Obstruction | Bile Duct Obstructions | Duct Obstruction, Bile | Duct Obstructions, Bile | Obstruction, Bile Duct | Obstructions, Bile Duct
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00014Abiraterone0.001471%
BADD_D00047Afatinib0.000533%
BADD_D00100Ambrisentan0.000866%
BADD_D00151Apixaban0.000265%
BADD_D00271Bicalutamide0.006444%
BADD_D00349Capecitabine0.000533%
BADD_D00504Clopidogrel0.000098%
BADD_D00511Clozapine0.019617%
BADD_D00775Enzalutamide0.001471%
BADD_D00858Everolimus0.001825%
BADD_D00979Furosemide0.000127%
BADD_D01009Gemcitabine0.000533%
BADD_D01024Glipizide--
BADD_D01096Hydromorphone0.000826%
BADD_D01119Ibrutinib0.001066%
BADD_D01253Lenalidomide0.008106%
BADD_D01258Leucovorin0.011662%
BADD_D01336Macitentan0.000226%
BADD_D01653Paclitaxel0.000533%
BADD_D01654Palbociclib0.000533%
BADD_D01798Pomalidomide0.001158%
BADD_D01822Prasugrel0.001762%
BADD_D01922Regorafenib0.002664%
BADD_D01933Ribavirin0.018131%
BADD_D02029Sitagliptin0.001125%
BADD_D02058Sorafenib0.001332%
BADD_D02100Sunitinib0.000533%
BADD_D02105Tacrolimus0.001419%
BADD_D02192Thalidomide--
BADD_D02236Tofacitinib0.001158%
The 1th Page    1 2    Next   Last    Total 2 Pages